未知股票 BCLI 深 沪
等待开盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 1103.48万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 1.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) Estimate
Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 60.78 percent increase over losses of $(0.51) per share from the
今天 06:49
Brainstorm Cell secures $1M strategic financing
Brainstorm Cell Therapeutics (BCLI) has entered into a definitive agreement for a strategic private placement of $1M. The common stock was priced at $0.60 per share, representing a significant premium...
02-20 20:18
BRIEF-Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
BRIEF-Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market Feb 20 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.PK : BRAINSTORM CELL THERAPEUTICS ANNOUNCES $1 MILLION STRATEGIC FINANCING AT PREMIUM TO MARKET Source text: ID:nPnrPyRQa Further company coverage
02-20 19:10
Brainstorm Cell Therapeutics Secures New Convertible Debt Financing
Brainstorm Cell Therapeutics ( ($BCLI) ) has provided an announcement. On Decem...
01-10 06:06
BRIEF-Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Aug 14 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.PK: BRAINSTORM CELL THERAPEUTICS ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nPn47fLT8a Furth...
2025-08-14 20:07
Brainstorm Cell Therapeutics Inc <BCLI.PK> expected to post a loss of 37 cents a share - Earnings Preview
Brainstorm Cell Therapeutics Inc BCLI.PK is expected to show no change in quarterly revenue when it reports results on August 14 for the period ending June 30 2025 LSEG's mean analyst estimate for Br...
2025-08-09 01:48
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notice from Nasdaq effective July 18, 2025.
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notic...
2025-07-18 04:42
BUZZ-U.S. STOCKS ON THE MOVE- Moderna, BrainStorm Cell, General Dynamics
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes largely...
2025-07-08 23:56
BRIEF-FDA Review Of Citizen Petition Offers A Fresh Look At NurOwn®'S Evidence Of Treatment Effectiveness
July 8 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.O: FDA REVIEW OF CITIZEN PETITION OFFERS A FRESH LOOK AT NUROWN®'S EVIDENCE OF TREATMENT EFFECTIVENESS BRAINSTORM CELL THERAPEUTICS INC - TO CO...
2025-07-08 19:32
Brainstorm Cell Therapeutics Files Prospectus For Offer & Sale Of Up To 2.8M Shares Of Common Stock By Selling Stockholder
https://www.sec.gov/Archives/edgar/data/1137883/000110465925062607/tm2518806d1_s3.htm
2025-06-26 04:47
